ABBOTT LABORATORIES — Director's Dealing 2010

May 19, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-05-17

Reporting Person: Blaser Brian J (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-05-17	Common shares without par value	A	13000	—	Acquired	40559	Direct
2010-05-17	Common shares without par value	A	14000	—	Acquired	54559	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-05-17	Option (right to buy)	$48.34	A	19000	Acquired	2020-05-16	Common shares (19000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	5499	Indirect

Footnotes

F1: These shares represent a performance vested restricted stock award under the Abbott Laboratories 2009 Incentive Stock Program. The award has a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The award vests on the third anniversary of the grant date and includes the right to have stock withheld for tax purposes.

F3: Balance in the Abbott Laboratories Stock Retirement Trust as of May 18, 2010.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,334 on 5/17/2011, 6,333 on 5/17/2012, and 6,333 on 5/17/2013.